Study on the Selection of the Targets of Esophageal Carcinoma and Interventions of Ginsenosides Based on Network Pharmacology and Bioinformatics

<div>Docking modes of ginsenosides with EpCAM. (a) Original ligand (DMU301), (b) ginsenoside Rg3, (c) ginsenoside Rh2, (d) ginsenoside Rg5, and (e) ginsenoside Rk3.</div>

Evidence-Based Complementary and Alternative Medicine

fig5

Figure 5

Figure 5: Study on the Selection of the Targets of Esophageal Carcinoma and Interventions of Ginsenosides Based on Network Pharmacology and Bioinformatics 

Figure 5 | Study on the Selection of the Targets of Esophageal Carcinoma and Interventions of Ginsenosides Based on Network Pharmacology and Bioinformatics 